SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Gutkovich J.)
 

Sökning: WFRF:(Gutkovich J.) > Epithelioid hemangi...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00009152naa a2201429 4500
001oai:lup.lub.lu.se:14ce555d-70c8-4c79-a869-0b207a20c1c2
003SwePub
008211220s2021 | |||||||||||000 ||eng|
024a https://lup.lub.lu.se/record/14ce555d-70c8-4c79-a869-0b207a20c1c22 URI
024a https://doi.org/10.1016/j.esmoop.2021.1001702 DOI
040 a (SwePub)lu
041 a engb eng
042 9 SwePub
072 7a for2 swepub-publicationtype
072 7a ref2 swepub-contenttype
100a Stacchiotti, S.u Istituto Nazionale dei Tumori4 aut
2451 0a Epithelioid hemangioendothelioma, an ultra-rare cancer : a consensus paper from the community of experts
264 1b Elsevier BV,c 2021
520 a Epithelioid hemangioendothelioma (EHE) is an ultra-rare, translocated, vascular sarcoma. EHE clinical behavior is variable, ranging from that of a low-grade malignancy to that of a high-grade sarcoma and it is marked by a high propensity for systemic involvement. No active systemic agents are currently approved specifically for EHE, which is typically refractory to the antitumor drugs used in sarcomas. The degree of uncertainty in selecting the most appropriate therapy for EHE patients and the lack of guidelines on the clinical management of the disease make the adoption of new treatments inconsistent across the world, resulting in suboptimal outcomes for many EHE patients. To address the shortcoming, a global consensus meeting was organized in December 2020 under the umbrella of the European Society for Medical Oncology (ESMO) involving >80 experts from several disciplines from Europe, North America and Asia, together with a patient representative from the EHE Group, a global, disease-specific patient advocacy group, and Sarcoma Patient EuroNet (SPAEN). The meeting was aimed at defining, by consensus, evidence-based best practices for the optimal approach to primary and metastatic EHE. The consensus achieved during that meeting is the subject of the present publication.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng
653 a diagnosis
653 a epithelioid hemangioendothelioma
653 a guidelines
653 a management
653 a sarcoma
653 a treatment
700a Miah, A. B.u Institute of Cancer Research London4 aut
700a Frezza, A. M.u Istituto Nazionale dei Tumori4 aut
700a Messiou, C.u Institute of Cancer Research London4 aut
700a Morosi, C.u Istituto Nazionale dei Tumori4 aut
700a Caraceni, A.u Istituto Nazionale dei Tumori4 aut
700a Antonescu, C. R.u Memorial Sloan-Kettering Cancer Center4 aut
700a Bajpai, J.u Homi Bhabha National Institute4 aut
700a Baldini, E.u Brigham and Women's Hospital / Harvard Medical School4 aut
700a Bauer, S.u University Hospital Essen4 aut
700a Biagini, R.u National Cancer Institute Regina Elena4 aut
700a Bielack, S.u Klinikum Stuttgart Olgahospital4 aut
700a Blay, J. Y.u Claude Bernard University Lyon 14 aut
700a Bonvalot, S.u PSL University4 aut
700a Boukovinas, I.u NORDIX4 aut
700a Bovee, J. V.M.G.u Leiden University Medical Centre4 aut
700a Boye, K.u Norwegian Radium Hospital4 aut
700a Brodowicz, T.u Medical University of Vienna4 aut
700a Callegaro, D.u Istituto Nazionale dei Tumori4 aut
700a De Alava, E.u University of Seville,University Hospital Virgen del Rocío4 aut
700a Deoras-Sutliff, M.u The EHE Foundation4 aut
700a Dufresne, A.u Claude Bernard University Lyon 14 aut
700a Eriksson, M.u Lund University,Lunds universitet,Medicinsk onkologi,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Medical oncology,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine,LUCC: Lund University Cancer Centre,Other Strong Research Environments4 aut0 (Swepub:lu)onk-mer
700a Errani, C.u Rizzoli Orthopedic Institute4 aut
700a Fedenko, A.u P.A. Hertzen Moscow Oncology Research Institute4 aut
700a Ferraresi, V.u National Cancer Institute Regina Elena4 aut
700a Ferrari, A.u Istituto Nazionale dei Tumori4 aut
700a Fletcher, C. D.M.u Brigham and Women's Hospital / Harvard Medical School4 aut
700a Garcia del Muro, X.u Catalan Institute of Oncology4 aut
700a Gelderblom, H.u Leiden University Medical Centre4 aut
700a Gladdy, R. A.u University of Toronto4 aut
700a Gouin, F.u Centre Léon Bérard4 aut
700a Grignani, G.u Institute for Cancer Research and Treatment, Candiolo4 aut
700a Gutkovich, J.u NYU Langone,The EHE Foundation4 aut
700a Haas, R.u Antoni Van Leeuwenhoek Hospital,Leiden University Medical Centre4 aut
700a Hindi, N.u University of Seville4 aut
700a Hohenberger, P.u Heidelberg University4 aut
700a Huang, P.u Institute of Cancer Research London4 aut
700a Joensuu, H.u Helsinki University Central Hospital4 aut
700a Jones, R. L.u Institute of Cancer Research London4 aut
700a Jungels, C.u Institut Jules Bordet4 aut
700a Kasper, B.u Heidelberg University4 aut
700a Kawai, A.u National Cancer Center Hospital, Japan4 aut
700a Le Cesne, A.u Institut Gustave Roussy4 aut
700a Le Grange, F.u University College London Hospital4 aut
700a Leithner, A.u Medical University of Graz4 aut
700a Leonard, H.4 aut
700a Lopez Pousa, A.u Hospital de Sant Pau4 aut
700a Martin Broto, J.u Hospital Fundación Jiménez Díaz4 aut
700a Merimsky, O.u Tel-Aviv University4 aut
700a Merriam, P.u Dana-Farber Cancer Institute4 aut
700a Miceli, R.u Istituto Nazionale dei Tumori4 aut
700a Mir, O.u Institut Gustave Roussy4 aut
700a Molinari, M.u University of Pittsburgh Medical Center4 aut
700a Montemurro, M.u Lausanne University Hospital4 aut
700a Oldani, G.u Geneva University Hospital4 aut
700a Palmerini, E.u Rizzoli Orthopedic Institute4 aut
700a Pantaleo, M. A.u St. Orsola-Malpighi University Hospital4 aut
700a Patel, S.u University of Texas4 aut
700a Piperno-Neumann, S.u Curie Institute, Paris4 aut
700a Raut, C. P.u Brigham and Women's Hospital / Harvard Medical School,Harvard Medical School4 aut
700a Ravi, V.u University of Texas4 aut
700a Razak, A. R.A.u University of Toronto4 aut
700a Reichardt, P.u HELIOS Klinikum Berlin-Buch4 aut
700a Rubin, B. P.u Cleveland Clinic Foundation4 aut
700a Rutkowski, P.u The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology4 aut
700a Safwat, A. A.u Aarhus University Hospital4 aut
700a Sangalli, C.u Istituto Nazionale dei Tumori4 aut
700a Sapisochin, G.u University of Toronto4 aut
700a Sbaraglia, M.u University Hospital of Padua4 aut
700a Scheipl, S.u Medical University of Graz4 aut
700a Schöffski, P.u Leuven Cancer Institute4 aut
700a Strauss, D.u Institute of Cancer Research London4 aut
700a Strauss, S. J.u University College London Hospital4 aut
700a Sundby Hall, K.u Norwegian Radium Hospital4 aut
700a Tap, W. D.u Memorial Sloan-Kettering Cancer Center4 aut
700a Trama, A.u Istituto Nazionale dei Tumori4 aut
700a Tweddle, A.u Royal Marsden Hospital, London4 aut
700a van der Graaf, W. T.A.u Antoni Van Leeuwenhoek Hospital4 aut
700a Van De Sande, M. A.J.u Leiden University Medical Centre4 aut
700a Van Houdt, W.u Antoni Van Leeuwenhoek Hospital4 aut
700a van Oortmerssen, G.u Leiden University4 aut
700a Wagner, A. J.u Dana-Farber Cancer Institute4 aut
700a Wartenberg, M.u Sarcoma Patients EuroNet (SPAEN)4 aut
700a Wood, J.u Royal Marsden NHS Foundation Trust4 aut
700a Zaffaroni, N.u Istituto Nazionale dei Tumori4 aut
700a Zimmermann, C.u University of Toronto4 aut
700a Casali, P. G.u Istituto Nazionale dei Tumori4 aut
700a Dei Tos, A. P.u University Hospital of Padua4 aut
700a Gronchi, A.u Istituto Nazionale dei Tumori4 aut
710a Istituto Nazionale dei Tumorib Institute of Cancer Research London4 org
773t ESMO Opend : Elsevier BVg 6:3q 6:3x 2059-7029
856u http://dx.doi.org/10.1016/j.esmoop.2021.100170x freey FULLTEXT
856u http://www.esmoopen.com/article/S2059702921001307/pdf
8564 8u https://lup.lub.lu.se/record/14ce555d-70c8-4c79-a869-0b207a20c1c2
8564 8u https://doi.org/10.1016/j.esmoop.2021.100170

Hitta via bibliotek

  • ESMO Open (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy